Advertisement

Topics

Messe Frankfurt GmbH Company Profile

17:37 EST 14th December 2018 | BioPortfolio

Within the German Equity Forum Fall 2006 more than 200 listed companies will hold their analyst conference and will present their 3rd quarter results to analysts and institutional investors. The presentations are hosted and moderated by experts of our Main Sponsors.
The timetable of the analyst conferences can be found here

Location

Ludwig-Erhard-Anlage 1
Frankfurt
60327
Germany

Contact

Phone: 49 69 75 75-30 00
Fax: 49 69 75 75-30 01
Email: eigenkapitalforum@deutsche-boerse.com


News Articles [545 Associated News Articles listed on BioPortfolio]

Rückblick: Hannover Messe 2017 – "Schaufenster Bioökonomie"

Auch 2017 war die BIOPRO Baden-Württemberg GmbH auf der weltweit wichtigsten Industriemesse, der Hannover Messe, mit einem Gemeinschaftsstand vertreten. Zusammen mit der Fachagentur Nachwachsende Roh...

Processing it all, day 1 — some of the key innovations from the show floor at ACHEMA 2018

As thousands of visitors flock to Frankfurt for the world forum and leading show for the process industries, we take a sneaky peek at some of the innovations that will be on offer from exhibitors in t...

MorphoSys-Aktie: MOR106 an Novartis lizensiert - Neubewertungsphase

Frankfurt am Main (www.aktiencheck.de) - MorphoSys-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, bestätigen in einer aktuellen Akti...

Medigene-Aktie: MDG1011-klinische Studie gestartet - Kursziel angehoben, kaufen!

Frankfurt am Main (www.aktiencheck.de) - Medigene-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, raten in einer aktuellen Aktienanal....

MorphoSys: Guter Lauf bei MOR208 - MOR106 kommt dazu - Aktie hochgestuft!

Frankfurt am Main (www.aktiencheck.de) - MorphoSys-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, stufen in einer aktuellen Aktienan....

Medigene: Erster Erfolgsmeilenstein aus der BLUE-Kooperation

Frankfurt am Main (www.aktiencheck.de) - Medigene-Aktienanalyse der EQUI.TS GmbH: Thomas J. Schießle, Aktienexperte der EQUI.TS GmbH, rät in einer aktuellen Aktienanalyse weiterhin zum Kauf der Akt....

BRAIN-Aktie: Q2/2018 etwas besser - warten auf mehr Wachstum

Frankfurt am Main (www.aktiencheck.de) - BRAIN-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, raten in einer aktuellen Aktienanalyse....

Medigene: Rekrutierungsverzug bei MDG1011 adressiert - Immunwirkstoff-Zukauf passt - Operations im Plan

Frankfurt am Main (www.aktiencheck.de) - Medigene-Aktienanalyse der EQUI.TS GmbH: Thomas J. Schießle, Analyst der EQUI.TS GmbH, rät in einer aktuellen Aktienanalyse weiterhin zum Kauf der Aktie des....

PubMed Articles [21 Associated PubMed Articles listed on BioPortfolio]

18th Experts Meeting Parkinson in Frankfurt / Main.

The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience.

Correction: Health Impact of the Heatwave of 2015: Hospital Admissions in Frankfurt/Main, Germany.

MRI-based pelvimetric measurements as predictors for a successful vaginal breech delivery in the Frankfurt Breech at term cohort (FRABAT).

The purpose of this study was to investigate the role of the maternal pelvis, assessed by MRI pelvimetry in nulliparous women expecting a term fetus in breech presentation, to predict a successful and...

A comparison of different farrowing systems - Part 1: Effects on the activity of the sow.

The aim of this study was to determine whether a 3-axis accelerometer (MSR 145B V5.106, MSR Electronics GmbH, Seuzach, Switzerland) can continuously record and display the activity behaviour of sows o...

Clinical Trials [54 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study

Prospective observational multicenter study to evaluate copeptin as a prognostic marker in patients with an acute cerebrovascular event. It includes four groups of patients, mainly dependi...

R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis

Purpose: to evaluate an efficacy of chemotherapy regimens R-DA-EPOCH-21 and R-mNHL-BFM-90 with and without autologous hematopoietic stem cells transplantation (auto-SCT) in newly diagnosed...

Companies [580 Associated Companies listed on BioPortfolio]

Messe Frankfurt GmbH

Within the German Equity Forum Fall 2006 more than 200 listed companies will hold their analyst conference and will present their 3rd quarter results to analysts and institutional investors. The prese...

PharmaNet GmbH (Frankfurt Office)

Global full service provider in clinical drug development

GYMWATCH GmbH

GYMWATCH GmbH develops advanced fitness technologies and devices. Based in Darmstadt, Germany, near Frankfurt, the company’s first product is the patented GYMWATCH Sensor, wh...

Messe Dusseldorf North America

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

More Information about "Messe Frankfurt GmbH" on BioPortfolio

We have published hundreds of Messe Frankfurt GmbH news stories on BioPortfolio along with dozens of Messe Frankfurt GmbH Clinical Trials and PubMed Articles about Messe Frankfurt GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Messe Frankfurt GmbH Companies in our database. You can also find out about relevant Messe Frankfurt GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record